September 19, 2022
Next-generation platform makes hollow-fiber perfusion technology commercially relevant and delivers advanced software to support cGMP LAKEWOOD, CO, US – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announces the launch of its Quantum Flex Cell Expansion System, a bioreactor platform that supports process development through to commercial manufacturing for the cell and gene [...]
September 19, 2022
Instrument Will Enable Near Real-Time Detection of Biomarkers and Drug Targets Fayetteville, AR - VIC Foundry, in collaboration with the University of Buffalo, has been awarded a $259,000 grant from the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program. STTR grants support research and development to de-risk new technologies that [...]
FLUXION LAUNCHES A FULLY PACKAGED ION CHANNEL SCREENING SOLUTION
September 19, 2022
A complete system for lead-to-answer screening in ion channel assays Alameda, CA - Fluxion Biosciences, a global leader in automated patch clamp systems for ion channel drug discovery, today announced the release of an integrated and affordable solution for simplifying automated ion channel assays. Ion channels are the third most significant drug target, after kinases [...]
Scispot launches Datarooms to automate and control lab data sharing
September 16, 2022
Across the life science industry, companies are feeling the pressure to lower the cost of product development, speed up development timelines, and improve success rates. To achieve these goals, life science R&D is moving towards a distributed and virtual research model with collaboration between multidisciplinary teams in different labs and often in different organizations. Outsourcing [...]
Streck Announces Series B Investment in Ceres Nanosciences
September 16, 2022
La Vista, Nebraska – Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The funds from this investment will be used to accelerate the development and commercialization of both diagnostic and research use products utilizing Ceres’ Nanotrap® technology platform. “Streck has a deep presence in and knowledge of the diagnostics industry and shares our commitment to building [...]
LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research
September 16, 2022
LGC this week opened a state-of-the-art facility at the Oxford Technology Park (OTP), which will serve both as the new home of The Native Antigen Company (TNAC), part of LGC Clinical Diagnostics, and as the host site of an advanced workflow applications laboratory for LGC Biosearch Technologies. The laboratory was officially opened by Dame Sarah [...]
September 16, 2022
NEWARK, Calif. -- BioChain Institute Inc., ("BioChain"), a leader in high-quality processed bio-sample products and services, is excited to officially be a 10X Visium Certified Service Provider, providing custom-tailored whole transcriptome services and off the shelf Visium characterized tissues, further expanding its spatial biology catalog. "Everyone here at BioChain is proud to be expanding our spatial [...]
September 16, 2022
Kickoff of final construction phase for the new bioprocess building Site’s multifunctional space now 3,600 m² New construction receives platinum sustainability certificate from the German Sustainable Building Council Jülich/Hamburg -- The globally positioned Eppendorf Group is expanding its bioprocess site in Jülich, Germany with the construction of a new state-of-the-art multifunctional building. The topping-out ceremony [...]
September 15, 2022
UPPSALA, Sweden -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, successfully completed extended concordance testing on Olink’s platforms (Olink® Target 48/96 and Olink® Explore), fulfilling specific requirements that supplement the Olink quality acceptance criteria. This latest validation was initiated by and implemented in cooperation with [...]
FUJIFILM Cellular Dynamics Announces the Appointment of Dr. Ilyas Singeç as Chief Scientific Officer
September 15, 2022
MADISON, Wis., -- FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSCs), today announces the appointment of Ilyas Singeç, M.D., as chief scientific officer effective September 12. In this newly created strategic role, Dr. Singeç will define the Company’s future iPSC technological pipeline. In his role as part [...]

